Intracranial Aneurysm Market Size, Share, Growth and Forecast (2026 - 2036)

Intracranial Aneurysm Market Forecast and Outlook By Fact.MR

• In 2025, the intracranial aneurysm market was valued at USD 1.8 billion.
• Based on revised Fact.MR analysis, demand for intracranial aneurysm treatment products is estimated to grow to USD 2.0 billion in 2026 and USD 5.8 billion by 2036.
• Fact.MR projects a CAGR of 11.1% during the forecast period.

Summary of Intracranial Aneurysm Market

• Market Definition
  • The market includes devices and procedures used to treat intracranial aneurysms through endovascular coiling, flow diversion, surgical clipping, and related neurovascular interventions.
• Demand Drivers
  • Neurovascular centers are expanding use of endovascular treatment because minimally invasive repair can reduce recovery burden in selected aneurysm cases.
  • Hospitals need advanced aneurysm treatment options because ruptured aneurysms can cause subarachnoid hemorrhage and life-threatening complications.
  •  Imaging departments support earlier detection where CTA, MRA, and cerebral angiography help guide treatment planning. [3]
• Key Segments Analyzed
  • By Type: Endovascular coiling is expected to hold approximately 42.0% share in 2026, supported by minimally invasive aneurysm occlusion use.
  • By Indication: Saccular aneurysms lead in 2026 with about 58.0% share, as they are the most commonly treated aneurysm morphology.
  • By Treatment Setting: Elective aneurysm repair accounts for around 39.0% share in 2026, driven by improved detection of unruptured aneurysms.
  • By End User: Hospitals hold nearly 66.0% share in 2026, since aneurysm repair needs imaging, surgical backup, and specialist staff.
  • By Sales Channel: Direct institutional sales are projected to lead with 48.0% share in 2026, as hospitals prefer qualified supplier contracts and clinical support.
  • By Geography: China leads growth through 2036 at 11.6% CAGR, supported by hospital expansion and rising neurointerventional capacity.
• Analyst Opinion at Fact.MR
  • Shambhu Nath Jha, Senior Analyst at Fact.MR, states, “Intracranial aneurysm treatment demand is no longer defined only by more detected cases. The stronger shift is toward aneurysm-specific device selection, flow control, and long-term occlusion confidence. Suppliers that can support complex anatomy, physician training, and reliable procedural outcomes will hold a better position than companies competing only on device availability.”
• Strategic Implications
  • Manufacturers should improve device deliverability because physicians evaluate aneurysm systems through navigation, deployment control, and anatomy fit.
  • Hospitals need specialist neurovascular programs to reduce referral delays and manage emergency aneurysm repair.
  • Distributors should prioritize clinical support and device availability because treatment delays can affect outcomes in high-risk aneurysm cases.
• Methodology
  • Market sizing uses aneurysm treatment procedures, device mix, neurovascular center capacity, and regional hospital purchasing patterns.
  • Analysis includes NIH aneurysm resources, neurosurgical guidance, FDA device information, company neurovascular product data, and hospital treatment references. [2]
  • Forecasts account for endovascular adoption, flow diverter use, imaging-led detection, specialist availability, and reimbursement conditions.

The market is projected to generate USD 3.7 billion in absolute opportunity between 2026 and 2036. Growth is supported by advanced neuroimaging, endovascular treatment adoption, flow diverter use, and wider access to neurovascular centers. NIH resources describe brain aneurysms as weakened blood vessels that may rupture and cause serious bleeding, which supports the need for diagnosis and treatment access. [1]

China leads with a projected CAGR of 11.6% through 2036, supported by hospital expansion and rising neurointerventional capacity. Germany follows at 11.3%, helped by advanced neurovascular care and structured reimbursement. The United States records 10.4%, with demand anchored in advanced imaging, device approvals, and specialist centers. India advances at 10.1%, backed by private hospital growth and wider stroke-care infrastructure. Japan grows at 9.4%, supported by aging-related cerebrovascular disease care. Brazil posts 8.9%, supported by urban hospital upgrades and improving access to interventional neurology.

Segmental Analysis

Intracranial Aneurysm Market Analysis by Type

Endovascular coiling is expected to hold 42.0% share in 2026 as it remains a widely used minimally invasive approach for aneurysm occlusion. Interventional neuroradiologists use coils to fill aneurysm sacs and reduce rupture risk by limiting blood flow into the aneurysm. AANS patient guidance identifies endovascular coiling as a treatment option for brain aneurysms, supporting its role in neurovascular care. Flow diverters are gaining ground in complex and wide-neck aneurysms, but coiling keeps a large base because physician familiarity and procedural availability are stronger. Surgical clipping remains important for selected anatomy and rupture scenarios. Poor device selection can raise recurrence risk and complicate follow-up management.

• Occlusion Role: Coiling helps reduce blood flow into aneurysm sacs and supports rupture-risk control.
• Procedure Familiarity: Many neurovascular centers have established workflows for coil-based repair.
• Anatomy Match: Coiling remains useful where aneurysm size, neck shape, and vessel access support safe placement.

Intracranial Aneurysm Market Analysis by Indication

Saccular aneurysms form the largest indication base because they are the most commonly diagnosed intracranial aneurysm type. Saccular aneurysms are projected to account for 58.0% share in 2026. These aneurysms often arise at arterial branch points and may be treated through coiling, clipping, flow diversion, or intrasaccular devices depending on size and neck anatomy. NIH resources describe brain aneurysms as vessel wall bulges that can rupture and cause bleeding, which supports active monitoring and treatment planning. Fusiform and dissecting aneurysms require more specialized approaches, but saccular aneurysms keep the main treatment base. Incomplete assessment can lead to unsuitable treatment choice and higher follow-up burden.

• Common Morphology: Saccular aneurysms represent the main treated aneurysm form in clinical practice.
• Device Choice: Treatment depends on aneurysm neck, size, rupture status, and vessel location.
• Follow-Up Need: Treated saccular aneurysms often require imaging surveillance to confirm durable occlusion.

Intracranial Aneurysm Market Analysis by Treatment Setting

Earlier detection of unruptured aneurysms is increasing elective repair decisions in specialist centers. Elective aneurysm repair is estimated to account for 39.0% share in 2026. Patients diagnosed through CTA, MRA, or angiography may be referred for preventive treatment when rupture risk is considered meaningful. NINDS notes that imaging tests can help diagnose aneurysms and guide treatment decisions. Emergency repair remains critical after rupture, yet elective treatment gains share where screening, incidental detection, and specialist access improve. Elective repair also allows more detailed device planning and patient counseling. Delayed referral can shift patients from planned care into emergency risk.

• Planned Intervention: Elective repair supports careful device selection and procedural preparation.
• Imaging Link: CTA, MRA, and angiography increase detection of aneurysms before rupture.
• Risk Review: Treatment planning depends on aneurysm size, location, patient risk, and clinical judgment.

Intracranial Aneurysm Market Analysis by End User

Hospitals lead demand because intracranial aneurysm repair requires angiography suites, hybrid operating rooms, neurosurgical backup, intensive care support, and trained neurovascular specialists. Hospitals are expected to hold 66.0% share in 2026. These facilities manage both ruptured aneurysm emergencies and planned endovascular procedures. CDC stroke resources highlight the seriousness of cerebrovascular events and the need for rapid care pathways [4]. Clinics support follow-up, yet treatment volume stays concentrated in hospitals with advanced neurovascular infrastructure. Weak hospital capacity can delay referral and limit access to minimally invasive treatment. Complex cases require coordinated imaging, anesthesia, surgery, and critical care.

• Specialist Infrastructure: Hospitals provide angiography, neurosurgery, anesthesia, and ICU support for aneurysm treatment.
• Emergency Capability: Ruptured aneurysms require rapid hospital-based intervention and post-procedure monitoring.
• Treatment Concentration: Advanced neurovascular procedures remain centered in high-capability institutions.

Intracranial Aneurysm Market Analysis by Sales Channel

Large hospitals prefer direct supplier engagement because neurovascular devices require product qualification, physician training, case support, and reliable inventory. Direct institutional sales are expected to account for 48.0% share in 2026. This channel leads where hospitals negotiate access to coils, flow diverters, clips, and microcatheters with technical support. Distributor sales remain important for regional hospitals and emerging markets. FDA medical device reporting guidance reinforces the need for traceability and performance monitoring for devices used in high-risk procedures [5]. Low-support channels can create risk when physicians need device-specific sizing, delivery, and deployment guidance.

• Case Support: Direct engagement helps hospitals access technical guidance during complex neurovascular procedures.
• Device Traceability: High-risk implants require clear documentation from supplier to patient use.
• Inventory Readiness: Hospitals need reliable availability of coils, catheters, and flow diversion systems.

Drivers, Restraints, and Opportunities

Earlier detection and minimally invasive treatment adoption are increasing demand for intracranial aneurysm care. Advanced imaging helps identify aneurysms before rupture, while endovascular tools allow treatment with less surgical disruption in selected cases. AANS identifies endovascular coiling and surgical clipping among treatment options for brain aneurysms, reflecting the clinical role of device-based management. Growth improves where hospitals connect imaging, referral, and neurointerventional capability. Flow diverters and intrasaccular devices are gaining importance where aneurysm anatomy is complex.

High procedure cost and specialist shortages restrain faster adoption. Intracranial aneurysm treatment requires trained neurosurgeons, interventional neuroradiologists, angiography infrastructure, and intensive care support. Neurovascular devices can be costly, and reimbursement varies across countries. Device migration, thrombosis, recurrence, and retreatment remain concerns. Smaller hospitals may lack the capability to treat complex aneurysms and refer cases to tertiary centers. Suppliers must prove device performance, training support, and long-term outcome value before hospitals expand adoption.

• Flow Diverter Expansion: Complex and wide-neck aneurysms create demand for devices that redirect blood flow and support vessel remodeling.
• AI Imaging Support: Diagnostic software can help identify aneurysm features and support rupture-risk assessment.
• Emerging Neurovascular Centers: Hospital infrastructure expansion creates opportunities for coil, catheter, and flow diversion suppliers.

Regional Analysis

The intracranial aneurysm market is assessed across North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, covering 40+ countries with demand profiles shaped by neurovascular specialist access, angiography infrastructure, imaging capacity, reimbursement systems, stroke care programs, and device availability.

Source: Fact.MR analysis, based on proprietary forecasting model and primary research

Asia Pacific Intracranial Aneurysm Market Analysis

Asia Pacific records the strongest growth because hospital expansion, neuroimaging access, and specialist neurovascular care are improving together. China is building a larger base of interventional neurology capacity, while India is expanding private hospital access in major cities. Japan adds stable demand through advanced healthcare infrastructure and aging-related cerebrovascular care. Fact.MR identifies Asia Pacific as the fastest-expanding regional opportunity due to healthcare investment and diagnostic potential. The region still faces access gaps outside leading urban hospitals. Growth depends on trained specialists, angiography infrastructure, device affordability, and referral pathways.

• China: China leads the country outlook as hospital expansion and rising neurointerventional capacity strengthen intracranial aneurysm treatment demand. The country is projected to grow at 11.6% CAGR by 2036. Endovascular coiling, flow diverters, and advanced imaging are gaining use across tertiary hospitals. Domestic device options improve access in selected product areas, while premium imported systems retain demand in complex cases. Physicians weigh aneurysm anatomy, device deliverability, and follow-up imaging needs before treatment selection.
• India: Private hospital expansion and wider stroke-care infrastructure support intracranial aneurysm treatment growth in India. Neurovascular care remains concentrated in large urban hospitals, yet access is improving through specialist centers. India is forecast to grow at 10.1% CAGR from 2026 to 2036. Cost sensitivity remains important, but severe and high-risk aneurysm cases require advanced treatment. Suppliers that combine device access with physician training can improve adoption.
• Japan: Aging-related cerebrovascular care and advanced imaging infrastructure support intracranial aneurysm demand in Japan. Hospitals focus on safe endovascular treatment and long-term monitoring for treated aneurysms. Japan is projected to post 9.4% CAGR through 2036. Growth is steady because specialist access is already structured. Suppliers with proven device performance and strong clinical support can maintain demand through replacement and procedure growth.

North America Intracranial Aneurysm Market Analysis

North America remains a high-value region because advanced imaging, specialist neurosurgical centers, and reimbursement systems support aneurysm treatment. The United States anchors regional demand through neurovascular device use, FDA approvals, and strong hospital infrastructure. Fact.MR states the U.S. market benefits from advanced healthcare infrastructure, reimbursement policies, and industry player presence. Hospitals evaluate devices through occlusion outcomes, complication profile, and physician familiarity. Demand is strong for flow diverters, embolization coils, and complex aneurysm treatment systems. Suppliers must prove procedural support and long-term outcome value to defend pricing.

• USA: The United States has a large base of neurovascular centers, advanced imaging facilities, and specialist physicians. Demand is supported by endovascular treatment, flow diverter use, and improved aneurysm detection. The country is projected to record 10.4% CAGR over the study period. Hospitals focus on devices that support complex anatomy and durable occlusion. Purchasers examine clinical evidence, reimbursement fit, and technical support before expanding supplier use.

Europe Intracranial Aneurysm Market Analysis

Europe shows strong demand where neurovascular care networks, medical device regulation, and reimbursement systems support advanced treatment. Germany leads regional growth through hospital infrastructure, specialist centers, and active adoption of neurointerventional technologies. Fact.MR reports Germany at 10.8% CAGR for 2025 to 2035, supported by healthcare infrastructure and neurovascular innovation.

• Germany: Germany benefits from advanced neurovascular infrastructure and structured hospital reimbursement. Demand is linked to endovascular repair, surgical clipping, and flow diversion for complex aneurysm cases. Germany is forecast to grow at 11.3% CAGR by 2036. Hospitals tend to favor suppliers with strong evidence, reliable case support, and proven device performance. Physician familiarity and treatment planning tools influence adoption more than broad product claims.

Latin America Intracranial Aneurysm Market Analysis

Latin America shows selective growth where private hospitals and tertiary centers are expanding access to neurovascular procedures. Brazil leads regional demand through urban hospital investment and improving interventional neurology capacity. Price sensitivity remains a key restraint, especially for flow diverters and complex embolization systems. Suppliers need strong distributor support, physician training, and reliable device availability. Growth improves when hospitals can maintain angiography infrastructure and referral pathways. Demand remains uneven because advanced aneurysm care is concentrated in major cities.

• Brazil: Urban hospital upgrades and improving access to interventional neurology support intracranial aneurysm treatment demand in Brazil. Complex aneurysm treatment remains concentrated in tertiary hospitals and private networks. Brazil is projected to expand at 8.9% CAGR over the study period. Hospitals often compare device cost with physician confidence and expected procedural outcomes. Distributors play a major role in product availability, case support, and training. Suppliers with dependable neurovascular portfolios can strengthen adoption.

Fact.MR analysis of regional demand covers Asia Pacific, North America, Europe, Latin America, and Middle East and Africa. The study assesses specialist availability, imaging capacity, angiography infrastructure, reimbursement, referral networks, and supplier support across major markets.

Competitive Aligners for Market Players

The intracranial aneurysm market is moderately concentrated because neurovascular implants require strong clinical evidence, precision manufacturing, physician training, and regulatory approval. Large global suppliers hold advantages because coils, flow diverters, microcatheters, and clipping systems require dependable device performance and specialist relationships. Regional suppliers compete where affordability and local access matter.

Competitive advantage depends on device deliverability, aneurysm anatomy coverage, occlusion performance, procedural support, and long-term safety data. Medtronic, Stryker, Johnson & Johnson, MicroVention, Terumo, B. Braun, Integra LifeSciences, MicroPort, Raumedic, and Balt represent supplier groups where neurovascular expertise and hospital relationships matter. Hospitals are less likely to switch suppliers when physicians are trained on specific systems.

The market is divided between established coil and clip products and advanced flow diversion or intrasaccular platforms. Suppliers that combine reliable device performance with physician education and case support can protect institutional demand. Emerging suppliers can gain ground where healthcare systems need lower-cost neurovascular access.

Key Players

• B. Braun Melsungen AG
• Integra LifeSciences Corporation
• Johnson & Johnson
• Medtronic plc
• MicroPort Scientific Corporation
• Raumedic AG
• Stryker Corporation
• Terumo Corporation
• MicroVention, Inc.
• Balt Group
• Penumbra, Inc.
• Phenox GmbH

Bibliography

• [1] National Institute of Neurological Disorders and Stroke. (2024). Cerebral Aneurysms. NINDS.
• [2] American Association of Neurological Surgeons. (2024). Cerebral Aneurysm. AANS.
• [3] Radiological Society of North America. (2024). Brain Aneurysm. RadiologyInfo.
• [4] Centers for Disease Control and Prevention. (2024). Stroke Facts. CDC.
•  [5] United States Food and Drug Administration. (2025, March 27). Medical Device Reporting (MDR): How to Report Medical Device Problems. FDA.

This Report Addresses

• Strategic intelligence on intracranial aneurysm treatment demand across endovascular coiling, flow diverters, surgical clipping, intrasaccular devices, and related neurovascular procedures globally.
• Market forecast from USD 2.0 billion in 2026 to USD 5.8 billion by 2036 at a CAGR of 11.1%.
• Growth opportunity mapping across China neurointerventional expansion, Germany specialist care, U.S. advanced device adoption, India private hospital growth, and Japan aging-related cerebrovascular care.
• Segment analysis by type, indication, treatment setting, end user, sales channel, and region.
• Regional outlook covering Asia Pacific neurovascular capacity growth, North America advanced device adoption, and Europe safety-controlled device evaluation.
• Competitive analysis of B. Braun, Integra LifeSciences, Johnson & Johnson, Medtronic, MicroPort Scientific, Raumedic, Stryker, Terumo, MicroVention, and Balt.
• Device adoption analysis covering aneurysm anatomy, device deliverability, occlusion durability, rupture-risk management, physician training, and imaging-guided treatment planning.
• Report delivered with market sizing, segment outlook, regional analysis, company profiling, and forecast assumptions.

Market Definition

The market covers devices, procedures, and treatment systems used to diagnose and treat intracranial aneurysms. It includes endovascular coiling, flow diverters, surgical clipping, intrasaccular devices, and supporting neurovascular access systems. The scope includes treatment of saccular, fusiform, mycotic, dissecting, and other aneurysm types across hospitals, clinics, neurovascular centers, and specialty care facilities.

Intracranial Aneurysm Market Inclusions

The study includes global and regional forecasts from 2026 to 2036. It covers embolization coils, flow diversion devices, aneurysm clips, access catheters, microcatheters, intrasaccular devices, and procedure-related support products used in intracranial aneurysm management. It includes emergency repair, elective repair, post-rupture management, follow-up monitoring, and outpatient neurovascular care.

Intracranial Aneurysm Market Exclusions

The scope excludes treatment of aortic, peripheral, and thoracic aneurysms unless devices are specifically used for intracranial aneurysm repair. It also excludes general stroke drugs, standard imaging systems sold without aneurysm treatment use, and neurosurgical tools not used in aneurysm repair. The focus stays on intracranial aneurysm treatment and related neurovascular intervention products.

Intracranial Aneurysm Market Research Methodology

• Primary Research
  • Interviews with neurosurgeons, interventional neuroradiologists, neurovascular center heads, hospital purchasing heads, stroke program directors, and neurovascular device distributors across major consuming regions.
• Desk Research
  • Uses neurology guidance, stroke and aneurysm care resources, medical device regulatory documentation, company product information, and neurovascular clinical references.
• Market-Sizing and Forecasting
  • Hybrid model using aneurysm procedure volumes, treatment adoption by device type, hospital neurovascular capacity, product pricing, replacement demand, and follow-up care requirements.
• Data Validation and Update Cycle
  • Forecasts were validated through neurovascular supplier checks, hospital purchasing patterns, procedure adoption trends, regulatory references, and regional specialist care indicators.